EE, V., CI, V. d. M., SP, S., JH, S., G, A., H, D., . . . A, H. (2024). Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis. Clinical immunology (Orlando, Fla.), 268, 110375. https://doi.org/10.1016/j.clim.2024.110375
Chicago Style (17th ed.) CitationEE, Vorsteveld, et al. "Clinical Exome Sequencing Data from Patients with Inborn Errors of Immunity: Cohort Level Diagnostic Yield and the Benefit of Systematic Reanalysis." Clinical Immunology (Orlando, Fla.) 268 (2024): 110375. https://doi.org/10.1016/j.clim.2024.110375.
MLA (9th ed.) CitationEE, Vorsteveld, et al. "Clinical Exome Sequencing Data from Patients with Inborn Errors of Immunity: Cohort Level Diagnostic Yield and the Benefit of Systematic Reanalysis." Clinical Immunology (Orlando, Fla.), vol. 268, 2024, p. 110375, https://doi.org/10.1016/j.clim.2024.110375.